Top Markets
#1 Ontology Gas Ontology Gas +31.11%
#2 Verus Coin Verus Coin +22.50%
#3 Status Status +21.81%
#4 Bitway Bitway +15.86%
#5 ETHGas ETHGas +15.11%
#6 Geodnet Geodnet +14.89%
#7 The Black Bull The Black Bull +11.57%
#8 Derive Derive +11.47%
#9 Curve DAO Curve DAO +11.06%
#10 Fake World Assets Fake World Assets +10.89%
Coin of the day
Ontology Gas Ontology Gas
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Kedudukan dalam Saham #25521
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Harga Saham
$9.81
Disegerakkan terakhir: 2025-03-18
Modal Pasaran
$48.68M
Perubahan (1 hari)
1.55%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan AlloVir, Inc. (ALVR)

Kategori

Healthcare
Bilangan saham terbitan bagi AlloVir, Inc. (ALVR)
Bilangan saham terbitan setakat June 2026: 23.80M
Menurut laporan kewangan terkini dan harga saham AlloVir, Inc., bilangan saham terbitan semasa ialah 23.80M. Pada akhir December 2023, syarikat mempunyai 4.47M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk AlloVir, Inc. (ALVR) dari 2018 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 23.80M 379.57%
2024 4.96M 10.90%
2023 4.47M 35.75%
2022 3.30M 22.10%
2021 2.70M 133.42%
2020 1.16M -36.07%
2019 1.81M 38.40%
2018 1.31M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 966.93%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 161.31%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 1,932.06%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 1,564.05%
US